0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Point-of-Care Genetic Testing Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-39G3979
Home | Market Reports | Science| Biological Sciences
Global Point of Care Genetic Testing Market Insights and Forecast to 2028
BUY CHAPTERS

Global Point-of-Care Genetic Testing Market Research Report 2025

Code: QYRE-Auto-39G3979
Report
September 2025
Pages:74
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Point-of-Care Genetic Testing Market Size

The global market for Point-of-Care Genetic Testing was valued at US$ 6644 million in the year 2024 and is projected to reach a revised size of US$ 7948 million by 2031, growing at a CAGR of 2.6% during the forecast period.

Point-of-Care Genetic Testing Market

Point-of-Care Genetic Testing Market

Point-of-care genetic testing identifies variations in the genetic sequence at the bedside – enabling clinicians to react and alter therapy based upon the results.
North American market for Point-of-Care Genetic Testing is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Point-of-Care Genetic Testing is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Point-of-Care Genetic Testing in Diagnostic Labs is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Point-of-Care Genetic Testing include Abbott (US), Roche (Switzerland), Thermo Fisher Scientific (US), Cepheid (US), IQuum (US), Biocartis (Switzerland), Idaho Technologies (US), Optigene (UK), Lumora (UK), etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Point-of-Care Genetic Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Point-of-Care Genetic Testing.
The Point-of-Care Genetic Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Point-of-Care Genetic Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Point-of-Care Genetic Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Point-of-Care Genetic Testing Market Report

Report Metric Details
Report Name Point-of-Care Genetic Testing Market
Accounted market size in year US$ 6644 million
Forecasted market size in 2031 US$ 7948 million
CAGR 2.6%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • POCT Cancer Kits
  • Molecular POC Kits
  • POCT In Antibiotic Therapies
  • Assay Cartridge
  • Other
Segment by Application
  • Diagnostic Labs
  • Bio-Pharmaceutical Industry
  • Academic Institutions
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Abbott (US), Roche (Switzerland), Thermo Fisher Scientific (US), Cepheid (US), IQuum (US), Biocartis (Switzerland), Idaho Technologies (US), Optigene (UK), Lumora (UK)
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Point-of-Care Genetic Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Point-of-Care Genetic Testing Market growing?

Ans: The Point-of-Care Genetic Testing Market witnessing a CAGR of 2.6% during the forecast period 2025-2031.

What is the Point-of-Care Genetic Testing Market size in 2031?

Ans: The Point-of-Care Genetic Testing Market size in 2031 will be US$ 7948 million.

Who are the main players in the Point-of-Care Genetic Testing Market report?

Ans: The main players in the Point-of-Care Genetic Testing Market are Abbott (US), Roche (Switzerland), Thermo Fisher Scientific (US), Cepheid (US), IQuum (US), Biocartis (Switzerland), Idaho Technologies (US), Optigene (UK), Lumora (UK)

What are the Application segmentation covered in the Point-of-Care Genetic Testing Market report?

Ans: The Applications covered in the Point-of-Care Genetic Testing Market report are Diagnostic Labs, Bio-Pharmaceutical Industry, Academic Institutions, Other

What are the Type segmentation covered in the Point-of-Care Genetic Testing Market report?

Ans: The Types covered in the Point-of-Care Genetic Testing Market report are POCT Cancer Kits, Molecular POC Kits, POCT In Antibiotic Therapies, Assay Cartridge, Other

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Point-of-Care Genetic Testing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 POCT Cancer Kits
1.2.3 Molecular POC Kits
1.2.4 POCT In Antibiotic Therapies
1.2.5 Assay Cartridge
1.2.6 Other
1.3 Market by Application
1.3.1 Global Point-of-Care Genetic Testing Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Diagnostic Labs
1.3.3 Bio-Pharmaceutical Industry
1.3.4 Academic Institutions
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Point-of-Care Genetic Testing Market Perspective (2020-2031)
2.2 Global Point-of-Care Genetic Testing Growth Trends by Region
2.2.1 Global Point-of-Care Genetic Testing Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Point-of-Care Genetic Testing Historic Market Size by Region (2020-2025)
2.2.3 Point-of-Care Genetic Testing Forecasted Market Size by Region (2026-2031)
2.3 Point-of-Care Genetic Testing Market Dynamics
2.3.1 Point-of-Care Genetic Testing Industry Trends
2.3.2 Point-of-Care Genetic Testing Market Drivers
2.3.3 Point-of-Care Genetic Testing Market Challenges
2.3.4 Point-of-Care Genetic Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Point-of-Care Genetic Testing Players by Revenue
3.1.1 Global Top Point-of-Care Genetic Testing Players by Revenue (2020-2025)
3.1.2 Global Point-of-Care Genetic Testing Revenue Market Share by Players (2020-2025)
3.2 Global Point-of-Care Genetic Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Point-of-Care Genetic Testing Revenue
3.4 Global Point-of-Care Genetic Testing Market Concentration Ratio
3.4.1 Global Point-of-Care Genetic Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Point-of-Care Genetic Testing Revenue in 2024
3.5 Global Key Players of Point-of-Care Genetic Testing Head office and Area Served
3.6 Global Key Players of Point-of-Care Genetic Testing, Product and Application
3.7 Global Key Players of Point-of-Care Genetic Testing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Point-of-Care Genetic Testing Breakdown Data by Type
4.1 Global Point-of-Care Genetic Testing Historic Market Size by Type (2020-2025)
4.2 Global Point-of-Care Genetic Testing Forecasted Market Size by Type (2026-2031)
5 Point-of-Care Genetic Testing Breakdown Data by Application
5.1 Global Point-of-Care Genetic Testing Historic Market Size by Application (2020-2025)
5.2 Global Point-of-Care Genetic Testing Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Point-of-Care Genetic Testing Market Size (2020-2031)
6.2 North America Point-of-Care Genetic Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Point-of-Care Genetic Testing Market Size by Country (2020-2025)
6.4 North America Point-of-Care Genetic Testing Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Point-of-Care Genetic Testing Market Size (2020-2031)
7.2 Europe Point-of-Care Genetic Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Point-of-Care Genetic Testing Market Size by Country (2020-2025)
7.4 Europe Point-of-Care Genetic Testing Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Point-of-Care Genetic Testing Market Size (2020-2031)
8.2 Asia-Pacific Point-of-Care Genetic Testing Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Point-of-Care Genetic Testing Market Size by Region (2020-2025)
8.4 Asia-Pacific Point-of-Care Genetic Testing Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Point-of-Care Genetic Testing Market Size (2020-2031)
9.2 Latin America Point-of-Care Genetic Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Point-of-Care Genetic Testing Market Size by Country (2020-2025)
9.4 Latin America Point-of-Care Genetic Testing Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Point-of-Care Genetic Testing Market Size (2020-2031)
10.2 Middle East & Africa Point-of-Care Genetic Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Point-of-Care Genetic Testing Market Size by Country (2020-2025)
10.4 Middle East & Africa Point-of-Care Genetic Testing Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott (US)
11.1.1 Abbott (US) Company Details
11.1.2 Abbott (US) Business Overview
11.1.3 Abbott (US) Point-of-Care Genetic Testing Introduction
11.1.4 Abbott (US) Revenue in Point-of-Care Genetic Testing Business (2020-2025)
11.1.5 Abbott (US) Recent Development
11.2 Roche (Switzerland)
11.2.1 Roche (Switzerland) Company Details
11.2.2 Roche (Switzerland) Business Overview
11.2.3 Roche (Switzerland) Point-of-Care Genetic Testing Introduction
11.2.4 Roche (Switzerland) Revenue in Point-of-Care Genetic Testing Business (2020-2025)
11.2.5 Roche (Switzerland) Recent Development
11.3 Thermo Fisher Scientific (US)
11.3.1 Thermo Fisher Scientific (US) Company Details
11.3.2 Thermo Fisher Scientific (US) Business Overview
11.3.3 Thermo Fisher Scientific (US) Point-of-Care Genetic Testing Introduction
11.3.4 Thermo Fisher Scientific (US) Revenue in Point-of-Care Genetic Testing Business (2020-2025)
11.3.5 Thermo Fisher Scientific (US) Recent Development
11.4 Cepheid (US)
11.4.1 Cepheid (US) Company Details
11.4.2 Cepheid (US) Business Overview
11.4.3 Cepheid (US) Point-of-Care Genetic Testing Introduction
11.4.4 Cepheid (US) Revenue in Point-of-Care Genetic Testing Business (2020-2025)
11.4.5 Cepheid (US) Recent Development
11.5 IQuum (US)
11.5.1 IQuum (US) Company Details
11.5.2 IQuum (US) Business Overview
11.5.3 IQuum (US) Point-of-Care Genetic Testing Introduction
11.5.4 IQuum (US) Revenue in Point-of-Care Genetic Testing Business (2020-2025)
11.5.5 IQuum (US) Recent Development
11.6 Biocartis (Switzerland)
11.6.1 Biocartis (Switzerland) Company Details
11.6.2 Biocartis (Switzerland) Business Overview
11.6.3 Biocartis (Switzerland) Point-of-Care Genetic Testing Introduction
11.6.4 Biocartis (Switzerland) Revenue in Point-of-Care Genetic Testing Business (2020-2025)
11.6.5 Biocartis (Switzerland) Recent Development
11.7 Idaho Technologies (US)
11.7.1 Idaho Technologies (US) Company Details
11.7.2 Idaho Technologies (US) Business Overview
11.7.3 Idaho Technologies (US) Point-of-Care Genetic Testing Introduction
11.7.4 Idaho Technologies (US) Revenue in Point-of-Care Genetic Testing Business (2020-2025)
11.7.5 Idaho Technologies (US) Recent Development
11.8 Optigene (UK)
11.8.1 Optigene (UK) Company Details
11.8.2 Optigene (UK) Business Overview
11.8.3 Optigene (UK) Point-of-Care Genetic Testing Introduction
11.8.4 Optigene (UK) Revenue in Point-of-Care Genetic Testing Business (2020-2025)
11.8.5 Optigene (UK) Recent Development
11.9 Lumora (UK)
11.9.1 Lumora (UK) Company Details
11.9.2 Lumora (UK) Business Overview
11.9.3 Lumora (UK) Point-of-Care Genetic Testing Introduction
11.9.4 Lumora (UK) Revenue in Point-of-Care Genetic Testing Business (2020-2025)
11.9.5 Lumora (UK) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Point-of-Care Genetic Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of POCT Cancer Kits
 Table 3. Key Players of Molecular POC Kits
 Table 4. Key Players of POCT In Antibiotic Therapies
 Table 5. Key Players of Assay Cartridge
 Table 6. Key Players of Other
 Table 7. Global Point-of-Care Genetic Testing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Point-of-Care Genetic Testing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 9. Global Point-of-Care Genetic Testing Market Size by Region (2020-2025) & (US$ Million)
 Table 10. Global Point-of-Care Genetic Testing Market Share by Region (2020-2025)
 Table 11. Global Point-of-Care Genetic Testing Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 12. Global Point-of-Care Genetic Testing Market Share by Region (2026-2031)
 Table 13. Point-of-Care Genetic Testing Market Trends
 Table 14. Point-of-Care Genetic Testing Market Drivers
 Table 15. Point-of-Care Genetic Testing Market Challenges
 Table 16. Point-of-Care Genetic Testing Market Restraints
 Table 17. Global Point-of-Care Genetic Testing Revenue by Players (2020-2025) & (US$ Million)
 Table 18. Global Point-of-Care Genetic Testing Market Share by Players (2020-2025)
 Table 19. Global Top Point-of-Care Genetic Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Point-of-Care Genetic Testing as of 2024)
 Table 20. Ranking of Global Top Point-of-Care Genetic Testing Companies by Revenue (US$ Million) in 2024
 Table 21. Global 5 Largest Players Market Share by Point-of-Care Genetic Testing Revenue (CR5 and HHI) & (2020-2025)
 Table 22. Global Key Players of Point-of-Care Genetic Testing, Headquarters and Area Served
 Table 23. Global Key Players of Point-of-Care Genetic Testing, Product and Application
 Table 24. Global Key Players of Point-of-Care Genetic Testing, Date of Enter into This Industry
 Table 25. Mergers & Acquisitions, Expansion Plans
 Table 26. Global Point-of-Care Genetic Testing Market Size by Type (2020-2025) & (US$ Million)
 Table 27. Global Point-of-Care Genetic Testing Revenue Market Share by Type (2020-2025)
 Table 28. Global Point-of-Care Genetic Testing Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 29. Global Point-of-Care Genetic Testing Revenue Market Share by Type (2026-2031)
 Table 30. Global Point-of-Care Genetic Testing Market Size by Application (2020-2025) & (US$ Million)
 Table 31. Global Point-of-Care Genetic Testing Revenue Market Share by Application (2020-2025)
 Table 32. Global Point-of-Care Genetic Testing Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 33. Global Point-of-Care Genetic Testing Revenue Market Share by Application (2026-2031)
 Table 34. North America Point-of-Care Genetic Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. North America Point-of-Care Genetic Testing Market Size by Country (2020-2025) & (US$ Million)
 Table 36. North America Point-of-Care Genetic Testing Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Europe Point-of-Care Genetic Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Europe Point-of-Care Genetic Testing Market Size by Country (2020-2025) & (US$ Million)
 Table 39. Europe Point-of-Care Genetic Testing Market Size by Country (2026-2031) & (US$ Million)
 Table 40. Asia-Pacific Point-of-Care Genetic Testing Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Asia-Pacific Point-of-Care Genetic Testing Market Size by Region (2020-2025) & (US$ Million)
 Table 42. Asia-Pacific Point-of-Care Genetic Testing Market Size by Region (2026-2031) & (US$ Million)
 Table 43. Latin America Point-of-Care Genetic Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Latin America Point-of-Care Genetic Testing Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Latin America Point-of-Care Genetic Testing Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Middle East & Africa Point-of-Care Genetic Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 47. Middle East & Africa Point-of-Care Genetic Testing Market Size by Country (2020-2025) & (US$ Million)
 Table 48. Middle East & Africa Point-of-Care Genetic Testing Market Size by Country (2026-2031) & (US$ Million)
 Table 49. Abbott (US) Company Details
 Table 50. Abbott (US) Business Overview
 Table 51. Abbott (US) Point-of-Care Genetic Testing Product
 Table 52. Abbott (US) Revenue in Point-of-Care Genetic Testing Business (2020-2025) & (US$ Million)
 Table 53. Abbott (US) Recent Development
 Table 54. Roche (Switzerland) Company Details
 Table 55. Roche (Switzerland) Business Overview
 Table 56. Roche (Switzerland) Point-of-Care Genetic Testing Product
 Table 57. Roche (Switzerland) Revenue in Point-of-Care Genetic Testing Business (2020-2025) & (US$ Million)
 Table 58. Roche (Switzerland) Recent Development
 Table 59. Thermo Fisher Scientific (US) Company Details
 Table 60. Thermo Fisher Scientific (US) Business Overview
 Table 61. Thermo Fisher Scientific (US) Point-of-Care Genetic Testing Product
 Table 62. Thermo Fisher Scientific (US) Revenue in Point-of-Care Genetic Testing Business (2020-2025) & (US$ Million)
 Table 63. Thermo Fisher Scientific (US) Recent Development
 Table 64. Cepheid (US) Company Details
 Table 65. Cepheid (US) Business Overview
 Table 66. Cepheid (US) Point-of-Care Genetic Testing Product
 Table 67. Cepheid (US) Revenue in Point-of-Care Genetic Testing Business (2020-2025) & (US$ Million)
 Table 68. Cepheid (US) Recent Development
 Table 69. IQuum (US) Company Details
 Table 70. IQuum (US) Business Overview
 Table 71. IQuum (US) Point-of-Care Genetic Testing Product
 Table 72. IQuum (US) Revenue in Point-of-Care Genetic Testing Business (2020-2025) & (US$ Million)
 Table 73. IQuum (US) Recent Development
 Table 74. Biocartis (Switzerland) Company Details
 Table 75. Biocartis (Switzerland) Business Overview
 Table 76. Biocartis (Switzerland) Point-of-Care Genetic Testing Product
 Table 77. Biocartis (Switzerland) Revenue in Point-of-Care Genetic Testing Business (2020-2025) & (US$ Million)
 Table 78. Biocartis (Switzerland) Recent Development
 Table 79. Idaho Technologies (US) Company Details
 Table 80. Idaho Technologies (US) Business Overview
 Table 81. Idaho Technologies (US) Point-of-Care Genetic Testing Product
 Table 82. Idaho Technologies (US) Revenue in Point-of-Care Genetic Testing Business (2020-2025) & (US$ Million)
 Table 83. Idaho Technologies (US) Recent Development
 Table 84. Optigene (UK) Company Details
 Table 85. Optigene (UK) Business Overview
 Table 86. Optigene (UK) Point-of-Care Genetic Testing Product
 Table 87. Optigene (UK) Revenue in Point-of-Care Genetic Testing Business (2020-2025) & (US$ Million)
 Table 88. Optigene (UK) Recent Development
 Table 89. Lumora (UK) Company Details
 Table 90. Lumora (UK) Business Overview
 Table 91. Lumora (UK) Point-of-Care Genetic Testing Product
 Table 92. Lumora (UK) Revenue in Point-of-Care Genetic Testing Business (2020-2025) & (US$ Million)
 Table 93. Lumora (UK) Recent Development
 Table 94. Research Programs/Design for This Report
 Table 95. Key Data Information from Secondary Sources
 Table 96. Key Data Information from Primary Sources
 Table 97. Authors List of This Report


List of Figures
 Figure 1. Point-of-Care Genetic Testing Picture
 Figure 2. Global Point-of-Care Genetic Testing Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Point-of-Care Genetic Testing Market Share by Type: 2024 VS 2031
 Figure 4. POCT Cancer Kits Features
 Figure 5. Molecular POC Kits Features
 Figure 6. POCT In Antibiotic Therapies Features
 Figure 7. Assay Cartridge Features
 Figure 8. Other Features
 Figure 9. Global Point-of-Care Genetic Testing Market Size by Application (2020-2031) & (US$ Million)
 Figure 10. Global Point-of-Care Genetic Testing Market Share by Application: 2024 VS 2031
 Figure 11. Diagnostic Labs Case Studies
 Figure 12. Bio-Pharmaceutical Industry Case Studies
 Figure 13. Academic Institutions Case Studies
 Figure 14. Other Case Studies
 Figure 15. Point-of-Care Genetic Testing Report Years Considered
 Figure 16. Global Point-of-Care Genetic Testing Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 17. Global Point-of-Care Genetic Testing Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 18. Global Point-of-Care Genetic Testing Market Share by Region: 2024 VS 2031
 Figure 19. Global Point-of-Care Genetic Testing Market Share by Players in 2024
 Figure 20. Global Top Point-of-Care Genetic Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Point-of-Care Genetic Testing as of 2024)
 Figure 21. The Top 10 and 5 Players Market Share by Point-of-Care Genetic Testing Revenue in 2024
 Figure 22. North America Point-of-Care Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. North America Point-of-Care Genetic Testing Market Share by Country (2020-2031)
 Figure 24. United States Point-of-Care Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Canada Point-of-Care Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Europe Point-of-Care Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Europe Point-of-Care Genetic Testing Market Share by Country (2020-2031)
 Figure 28. Germany Point-of-Care Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. France Point-of-Care Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. U.K. Point-of-Care Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Italy Point-of-Care Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Russia Point-of-Care Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Nordic Countries Point-of-Care Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Asia-Pacific Point-of-Care Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Asia-Pacific Point-of-Care Genetic Testing Market Share by Region (2020-2031)
 Figure 36. China Point-of-Care Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Japan Point-of-Care Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. South Korea Point-of-Care Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Southeast Asia Point-of-Care Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. India Point-of-Care Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Australia Point-of-Care Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Latin America Point-of-Care Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Latin America Point-of-Care Genetic Testing Market Share by Country (2020-2031)
 Figure 44. Mexico Point-of-Care Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Brazil Point-of-Care Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Middle East & Africa Point-of-Care Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Middle East & Africa Point-of-Care Genetic Testing Market Share by Country (2020-2031)
 Figure 48. Turkey Point-of-Care Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Saudi Arabia Point-of-Care Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. UAE Point-of-Care Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 51. Abbott (US) Revenue Growth Rate in Point-of-Care Genetic Testing Business (2020-2025)
 Figure 52. Roche (Switzerland) Revenue Growth Rate in Point-of-Care Genetic Testing Business (2020-2025)
 Figure 53. Thermo Fisher Scientific (US) Revenue Growth Rate in Point-of-Care Genetic Testing Business (2020-2025)
 Figure 54. Cepheid (US) Revenue Growth Rate in Point-of-Care Genetic Testing Business (2020-2025)
 Figure 55. IQuum (US) Revenue Growth Rate in Point-of-Care Genetic Testing Business (2020-2025)
 Figure 56. Biocartis (Switzerland) Revenue Growth Rate in Point-of-Care Genetic Testing Business (2020-2025)
 Figure 57. Idaho Technologies (US) Revenue Growth Rate in Point-of-Care Genetic Testing Business (2020-2025)
 Figure 58. Optigene (UK) Revenue Growth Rate in Point-of-Care Genetic Testing Business (2020-2025)
 Figure 59. Lumora (UK) Revenue Growth Rate in Point-of-Care Genetic Testing Business (2020-2025)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Accenture

SIMILAR REPORTS

RELATED REPORTS

Global Salt Active Nuclease Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-6W17226
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Parietal Bone Model Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34V19460
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Genome Editing Enzymes Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-6C20013
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Genome Editing Tool Enzymes Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-37K19803
Thu Sep 11 00:00:00 UTC 2025

Add to Cart